Previous Issue - Issue 61
Issue 61 | 2025
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Expert Corner
- Advertorials
- BioPharma Go to Digital Magazine
Issue 61
PREVIOUS ISSUE
Foreword
Ensuring Integrity in AI-Driven Pharmacovigilance
As the pharmaceutical industry accelerates AI adoption it is becoming increasingly clear that trust
Strategy
Modernising Asia's Drug Regulations
AI and Quantum Computing as catalysts for harmonised pharmaceutical oversight
Although Asias pharmaceutical sector produces close to half of the worlds specialty generics biologicals
Research & Development
Discovery Stage
The bedrock for preclinical development
The discovery stage of preclinical development involves testing small molecules and therapeutics in model systems
Clinical Trials
Transforming Clinical Trials
Harnessing wearables for Real-World Data (RWD) and Real-World Evidence (RWE) collection and analysis
Clinical trials are at a pivotal juncture in For decades clinical trials have largely relied on controlled environments
Manufacturing
TINY TECH, BIG IMPACT
The rise of nanobots in pulmonary therapeutics
Lung diseases cause millions of deaths each year making this group of diseases one of the primary causes of death
Information Technology
Toward Trustworthy AI in Pharma
Managing hallucination and bias in pharmacovigilance
Hallucination in the context of GenAI is not a metaphor it describes a process where an AI system generates
Exploring Artificial intelligence (AI) Potential in Pharma for Drug Discovery and Development
Drug discovery and development are complex costly and timeintensive processes with average timelines exceeding
Expert Corner
3D Printing for Special Patient Populations
Adoption increases when personalisation translates into visible clinical benefit and simpler use In pediatrics
AI/ML Driving Clinical Outcomes
I think the convergence of AI and machine learning with pharma marketing is going well beyond building brands
Listening First, Leading Forward
The global journey of Andrea von der Lippe
From her early days in sales in Germany to leading international markets across three continents
Advertorials
From Molecule to Market
Solving the fragmented approach in prefillable syringe development
Asia Pacific APAC is rapidly emerging as a global hub for biologics South Korea India Singapore and Thailand
Almac Clinical Services
Driving Innovation and Supply-Chain Excellence Across APAC
The market context in the region at the time made establishing our APAC headquarters in Singapore
BioPharma
Advances in Biotherapeutics
Transforming drug discovery and development
According to the US Food and Drug Administration FDA biotherapeutics also known as biologicals or biopharmaceuticals
Why Early CMC Strategy Matters for Asian Biotech
In July the FDA published Complete Response letters CRLs offering significant transparency
Navigating the Future
The regulatory revolution in gene therapy
The cell and gene therapies CGTs landscape is evolving rapidly with transformative potential to potentially cure
